This review attempts to reconcile the present dual view of the mechanisms operating in Amyotrophic Lateral Sclerosis (ALS). On one side, oxidative stress, mitochondrial damage and protein aggregation are considered as causative of the disease, as strongly supported by evidence obtained in models based on the expression of ALS-typical mutant SOD1. On the other hand, evidence from models expressing ALS-typical mutations in RNA-binding proteins such as FUS and TDP43 indicate that mRNA (dys)metabolism is a major pathway in this disease. A critical analysis of existing literature suggests that there may be more than one point of intersection
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
This review attempts to reconcile the present dual view of the mechanisms operating in Amyotrophic L...
This review attempts to reconcile the present dual view of the mechanisms operating in Amyotrophic L...
This review attempts to reconcile the present dual view of the mechanisms operating in Amyotrophic L...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
The mechanisms underlying motoneuron degeneration in amyotrophic lateral sclerosis (ALS), a neurodeg...
The mechanisms underlying motoneuron degeneration in amyotrophic lateral sclerosis (ALS), a neurodeg...
The mechanisms underlying motoneuron degeneration in amyotrophic lateral sclerosis (ALS), a neurodeg...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
This review attempts to reconcile the present dual view of the mechanisms operating in Amyotrophic L...
This review attempts to reconcile the present dual view of the mechanisms operating in Amyotrophic L...
This review attempts to reconcile the present dual view of the mechanisms operating in Amyotrophic L...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
Amyotrophic Lateral Sclerosis (ALS) is recognized as a very complex disease. As we have learned in t...
The mechanisms underlying motoneuron degeneration in amyotrophic lateral sclerosis (ALS), a neurodeg...
The mechanisms underlying motoneuron degeneration in amyotrophic lateral sclerosis (ALS), a neurodeg...
The mechanisms underlying motoneuron degeneration in amyotrophic lateral sclerosis (ALS), a neurodeg...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...
Evidence from patients with sporadic and familiar amyotrophic lateral sclerosis (ALS) and from model...